Crossvault Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $8.97M | Sell |
27,663
-1,825
| -6% | -$548K | 3.53% | 10 |
|
|
2022
Q1 | $8.44M | Buy |
29,488
+420
| +1% | +$108K | 2.72% | 15 |
|
|
2021
Q4 | $8.03M | Buy |
29,068
+2,401
| +9% | +$609K | 2.41% | 17 |
|
|
2021
Q3 | $6.16M | Sell |
26,667
-1,665
| -6% | -$411K | 1.94% | 27 |
|
|
2021
Q2 | $6.9M | Buy |
28,332
+4,145
| +17% | +$833K | 2.1% | 22 |
|
|
2021
Q1 | $4.52M | Sell |
24,187
-18
| -0.1% | -$3.52K | 1.61% | 26 |
|
|
2020
Q4 | $4.09M | Buy |
24,205
+1,930
| +9% | +$288K | 1.52% | 26 |
|
|
2020
Q3 | $3.3M | Buy |
22,275
+2,450
| +12% | +$379K | 1.43% | 25 |
|
|
2020
Q2 | $3.25M | Buy |
19,825
+8,250
| +71% | +$1.27M | 1.51% | 25 |
|
|
2020
Q1 | $1.61M | Hold |
11,575
| – | – | 0.9% | 32 |
|
|
2019
Q4 | $1.52M | Hold |
11,575
| – | – | 0.67% | 36 |
|
|
2019
Q3 | $1.29M | Sell |
11,575
-470
| -4% | -$52.3K | 0.62% | 34 |
|
|
2019
Q2 | $1.33M | Sell |
12,045
-25
| -0.2% | -$2.94K | 0.65% | 34 |
|
|
2019
Q1 | $1.57M | Sell |
12,070
-25
| -0.2% | -$3.04K | 0.81% | 32 |
|
|
2018
Q4 | $1.4M | Sell |
12,095
-550
| -4% | -$61.4K | 0.79% | 35 |
|
|
2018
Q3 | $1.36M | Hold |
12,645
| – | – | 0.7% | 33 |
|
|
2018
Q2 | $1.08M | Hold |
12,645
| – | – | 0.57% | 33 |
|
|
2018
Q1 | $978K | Hold |
12,645
| – | – | 0.56% | 36 |
|
|
2017
Q4 | $1.07M | Sell |
12,645
-50
| -0.4% | -$4.25K | 0.56% | 39 |
|
|
2017
Q3 | $1.09M | Hold |
12,695
| – | – | 0.62% | 37 |
|
|
2017
Q2 | $1.04M | Hold |
12,695
| – | – | 0.63% | 37 |
|
|
2017
Q1 | $1.07M | Sell |
12,695
-50
| -0.4% | -$4K | 0.66% | 39 |
|
|
2016
Q4 | $937K | Hold |
12,745
| – | – | 0.63% | 38 |
|
|
2016
Q3 | $1.02M | Hold |
12,745
| – | – | 0.71% | 37 |
|
|
2016
Q2 | $1M | Sell |
12,745
-50
| -0.4% | -$3.76K | 0.71% | 34 |
|
|
2016
Q1 | $921K | Hold |
12,795
| – | – | 0.68% | 34 |
|
|
2015
Q4 | $1.08M | Sell |
12,795
-500
| -4% | -$41.5K | 0.77% | 36 |
|
|
2015
Q3 | $1.11M | Sell |
13,295
-580
| -4% | -$49K | 0.87% | 34 |
|
|
2015
Q2 | $1.16M | Sell |
13,875
-4,000
| -22% | -$305K | 0.93% | 30 |
|
|
2015
Q1 | $1.3M | Hold |
17,875
| – | – | 1.04% | 33 |
|
|
2014
Q4 | $1.23M | Hold |
17,875
| – | – | 1.08% | 33 |
|
|
2014
Q3 | $1.16M | Sell |
17,875
-125
| -0.7% | -$7.91K | 1.09% | 30 |
|
|
2014
Q2 | $1.12M | Sell |
18,000
-50
| -0.3% | -$2.98K | 1.04% | 31 |
|
|
2014
Q1 | $1.06M | Sell |
18,050
-8,885
| -33% | -$496K | 1.03% | 31 |
|
|
2013
Q4 | $1.37M | Buy |
+26,935
| New | +$1.35M | 1.33% | 30 |
|
Other funds holding LLY
Crossvault Capital Management's LLY Position: Q2 2022 in Review
Crossvault Capital Management reduced its Eli Lilly (LLY) stake by 6.2% in Q2 2022, selling an estimated $548K and leaving 27,663 shares worth $8.97M. The position accounts for 3.53% of the portfolio, ranked #10.
Crossvault Capital Management first reported a position in LLY in Q4 2013 and has held it in 35 quarters since. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.
- Crossvault Capital Management held 27,663 shares of Eli Lilly worth $8.97M as of Q2 2022.
- Crossvault Capital Management sold 1,825 Eli Lilly shares in Q2 2022, an estimated $548K.
- Eli Lilly made up 3.53% of Crossvault Capital Management's portfolio in Q2 2022, its #10 holding.
- Crossvault Capital Management first reported a position in Eli Lilly in Q4 2013 and has held it in 35 quarters since.
- 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.
Based on Crossvault Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.